SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-004890
Filing Date
2023-07-14
Accepted
2023-07-14 10:28:11
Documents
33
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cnbx_i10q-053123.htm   iXBRL 10-Q 408854
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cnbx_ex3101.htm EX-31.1 10049
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cnbx_ex3102.htm EX-31.2 10196
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 5010
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4710
  Complete submission text file 0001683168-23-004890.txt   1756968

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cnbx-20230531.xsd EX-101.SCH 14535
7 XBRL CALCULATION FILE cnbx-20230531_cal.xml EX-101.CAL 27032
8 XBRL DEFINITION FILE cnbx-20230531_def.xml EX-101.DEF 29272
9 XBRL LABEL FILE cnbx-20230531_lab.xml EX-101.LAB 128393
10 XBRL PRESENTATION FILE cnbx-20230531_pre.xml EX-101.PRE 95810
27 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10q-053123_htm.xml XML 132748
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 231088266
SIC: 2834 Pharmaceutical Preparations